Johnson & Johnson Extends Tender Offer for Mentor Corporation
January 06 2009 - 4:22PM
PR Newswire (US)
NEW BRUNSWICK, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Johnson &
Johnson (NYSE:JNJ) today announced it has extended its previously
announced cash tender offer, through its wholly owned subsidiary,
Maple Merger Sub, Inc., for all outstanding shares of common stock
of Mentor Corporation (NYSE:MNT) until 5:00 p.m. (Eastern time), on
January 16, 2009, unless further extended. The tender offer was
originally scheduled to expire at 12:00 midnight (Eastern time), on
January 12, 2009. All other terms and conditions of the tender
offer remain unchanged. The condition of the tender offer relating
to the Hart-Scott-Rodino Antitrust Improvements Act has been
satisfied. Other regulatory clearances required for the closing of
the tender offer remain pending and Johnson & Johnson
anticipates receipt of those clearances on or prior to January 15,
2009. Accordingly, Johnson & Johnson has extended the tender
offer to reflect this timetable. The depositary for the tender
offer has advised Johnson & Johnson that, as of 12:00 p.m.
(Eastern time) today, a total of 609,983 shares of Mentor common
stock were validly tendered and not withdrawn (none of which are
subject to guaranteed delivery procedures), representing
approximately 1.8% of Mentor's outstanding common stock. Upon the
successful closing of the tender offer, shareholders of Mentor will
receive $31.00 in cash for each share of Mentor common stock
tendered in the tender offer, without interest and less any
required withholding taxes. Following the completion of the
acquisition, it is expected that Mentor will operate as a
stand-alone business unit reporting through ETHICON, Inc., a
Johnson & Johnson company. About Johnson & Johnson Caring
for the world, one person at a time...inspires and unites the
people of Johnson & Johnson. We embrace research and science --
bringing innovative ideas, products and services to advance the
health and well-being of people. Our 119,400 employees at more than
250 Johnson & Johnson companies work with partners in health
care to touch the lives of over a billion people every day,
throughout the world. Additional Information This press release is
neither an offer to purchase nor a solicitation of an offer to sell
shares of Mentor Corporation. Johnson & Johnson and Maple
Merger Sub, Inc. have filed a tender offer statement with the
Securities and Exchange Commission ("SEC"), and have mailed an
offer to purchase, forms of letter of transmittal and related
documents to Mentor shareholders. Mentor has filed with the SEC,
and has mailed to Mentor shareholders, a
solicitation/recommendation statement on Schedule 14D-9. These
documents contain important information about the tender offer and
shareholders of Mentor are urged to read them carefully. These
documents are available at no charge at the SEC's website at
http://www.sec.gov/. The tender offer statement and the related
materials may be obtained for free by directing a request by mail
to Georgeson Inc., 199 Water Street, New York, New York 10038 or by
calling toll-free (800) 213-0475 or (800) 445-1790. In addition, a
copy of the offer to purchase, letter of transmittal and certain
other related tender offer documents may be obtained free of charge
by directing a request to Johnson & Johnson at
http://www.jnj.com/, or Johnson & Johnson, One Johnson &
Johnson Plaza, New Brunswick, New Jersey 08933, Attn: Corporate
Secretary's Office. DATASOURCE: Johnson & Johnson CONTACT:
Press Contacts: Jeffrey J. Leebaw, +1-732-524-3350 or
+1-732-642-6608 (M) or Bill Price, +1-732-524-6623 or
+1-732-668-3735 (M); or Investor Contacts: Louise Mehrotra,
+1-732-524-6491 or Stan Panasewicz, +1-732-524-2524 Web Site:
http://www.jnj.com/
Copyright
Mentor (NYSE:MNT)
Historical Stock Chart
From Jan 2025 to Feb 2025
Mentor (NYSE:MNT)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about Mentor (MN) (New York Stock Exchange): 0 recent articles
More Mentor (MN) News Articles